申请人:Eli Lilly and Company
公开号:US06391901B1
公开(公告)日:2002-05-21
This application relates to novel compounds of formula I (and their pharmaceutically acceptable salts), as defined herein, processes and intermediates for their preparation, pharmaceutical formulations comprising the novel compounds of formula I, and the use of defined compounds of formula I as thrombin inhibitors.
这项申请涉及到式I的新化合物(及其药学上可接受的盐),如本文所定义,用于它们的制备的过程和中间体,包含式I的新化合物的药物配方,以及将式I的特定化合物用作凝血酶抑制剂。